Monday, 6 November 2017

FDA approves Roche drug for rare type of blood cancer

(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)